Clinical Trials Browser

Recurrence × ruxolitinib × 30 days × Clear all

Lymphoma, Recurrence

Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Thrombocythemia, Essential, Primary Myelofibrosis

Clinical Trials